Roberto Papait,Paola Cattaneo,Paolo Kunderfranco,Carolina Greco,Pierluigi Carullo,Alessandro Guffanti,Valentina Viganò,Giuliano Giuseppe Stirparo,Michael V. G. Latronico,Gerd Hasenfuss,Ju Chen,Gianluigi Condorelli

Abstract:Significance Cardiac failure is a leading cause of mortality worldwide and a major financial burden for healthcare systems. New tools for understanding cardiovascular disease and developing better therapeutic approaches are therefore needed. To this end, transcriptional regulation has been extensively studied in cardiac hypertrophy and failure, but there is still a lack of understanding of the epigenetic framework in which transcription factors act. Our report adds significant knowledge to the field because we demonstrate, in vivo, that a complex and specific epigenetic signature regulates gene expression by modulating promoters and enhancers, a large number of which have been described here. These findings advance our understanding of the mechanisms underlying this pathology.

Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy